Cite
HARVARD Citation
Earl, H. et al. (n.d.). Addition of gemcitabine to paclitaxel, epirubicin, and cyclophosphamide adjuvant chemotherapy for women with early-stage breast cancer (tAnGo): final 10-year follow-up of an open-label, randomised, phase 3 trial. Lancet oncology. 18 (6), pp. 755-769. [Online].